Do you consider adjuvant chemotherapy in a patient who has received ddMVAC preoperatively and had pT3pN2 disease at time of surgery?

No. There is no high level evidence of doing that. I would strongly favor clinical trial, e.g. AMBASSADOR is accruing (or active surveillance if no trial available).